Suchergebnisse - "Patel, Sanjay"

PubPharm (29)

1

Efficacy and safety of linagliptin in type 2 diabetes patients with self-reported hepatic disorders : A retrospective pooled analysis of 17 randomized, double-blind, placebo-controlled clinical trials

enthalten in: Journal of diabetes and its complications | 2016

von Inagaki, N. | Sheu, W. | Owens, D. | +4

2

Linagliptin plus metformin in patients with newly diagnosed type 2 diabetes and marked hyperglycemia

enthalten in: Postgraduate medicine | 2016

von Ross, S. | Caballero, A. | Del Prato, S. | +7

3

Comparable pharmacodynamics, efficacy, and safety of linagliptin 5 mg among Japanese, Asian and white patients with type 2 diabetes

enthalten in: Journal of diabetes investigation | 2016

von Sarashina, A. | Friedrich, C. | Crowe, S. | +4

4

Linagliptin and pioglitazone combination therapy versus monotherapy with linagliptin or pioglitazone : A randomised, double-blind, parallel-group, multinational clinical trial

enthalten in: Diabetes & vascular disease research | 2016

von Nauck, M. | di Domenico, M. | Patel, S. | +3

5

Efficacy and safety of linagliptin in Asian patients with type 2 diabetes mellitus inadequately controlled by metformin : A multinational 24-week, randomized clinical trial

enthalten in: Journal of diabetes | 2016

von Wang, W. | Yang, J. | Yang, G. | +5

6

Efficacy and Cardiovascular Safety of Linagliptin as an Add-On to Insulin in Type 2 Diabetes : A Pooled Comprehensive Post Hoc Analysis

enthalten in: Canadian journal of diabetes | 2016

von Zinman, B. | Ahrén, B. | Neubacher, D. | +3

7

Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes Mellitus

enthalten in: Clinical pharmacokinetics | 2015

von Retlich, S. | Duval, V. | Graefe-Mody, U. | +4

8

Cardiovascular safety of linagliptin in type 2 diabetes : a comprehensive patient-level pooled analysis of prospectively adjudicated cardiovascular events

enthalten in: Cardiovascular diabetology | 2015

von Rosenstock, J. | Marx, N. | Neubacher, D. | +4

9

Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®)

enthalten in: Diabetes & vascular disease research | 2015

von Marx, N. | Rosenstock, J. | Kahn, S. | +10

10

Initial combination of empagliflozin and linagliptin in subjects with type 2 diabetes

enthalten in: Diabetes care | 2015

von Lewin, A. | DeFronzo, R. | Patel, S. | +4

ErratumIn: Diabetes Care. 2015 Jun;38(6):1173. - PMID 25998299